AJCP / Meeting AbstrActs laboratory was averaging about 20.47 corrected reports per month for the prior 16 months. The laboratory goal was to have 16 or fewer corrected report occurrences per month. Aside from the number of corrected report occurrences, this laboratory was experiencing growth of 10.98% in resulting revenue generated test (RGT) volume year over year which would further challenge the laboratory in meeting their stated corrected report goal. The focus on corrected reports is an important quality metric because as the number of occurrences is reduced, the possibility of a negative impact on patient care and additional work in the laboratory being needed are also reduced. Methods: The PI methodology utilized to kick off our engagement was an occurrence tracking review with applied root cause analysis. Occurrence tracking data were collected from the five months prior to the engagement, which allowed us to retrospectively go back and apply root cause analysis to the available data. Through the application of these methodologies, the team was able to brainstorm ideas that could be piloted in the laboratory. Conclusion: This laboratory was able to obtain an overall reduction of corrected reports by 32% for the seven months following the PI implementation. In conclusion, it is recommended that all quality metrics focus on occurrence tracking and root cause analysis for each error that presents. It is through these tools that we can take a proactive approach in having information readily available in order to determine where to focus PI engagements to reduce errors.
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High Risk Subset of Grade 1 Endometrioid Endometrial Adenocarcinomas Associated With Aggressive Behavior
Daniel Sanchez, MD; Orlando Health, Orlando, FL Background: Conventional low-grade endometrioid endometrial adenocarcinomas have been associated with lower risk of cervical and adnexal involvement and extrauterine spread, and therefore lower stage at diagnosis. Most type 1, grade 1 endometrioid adenocarcinomas are PTEN deleted, express estrogen and progesterone receptors, and are p53 intact, which portends a better prognosis. Methodology: In our retrospective analysis, we examined 220 cases of type 1, grade 1 endometrioid endometrial adenocarcinomas (n = 220). Each case was reviewed with the pertinent H&E and immunohistochemistry, and the evaluated parameters included age of the patient, size of tumor, percent of myometrial involvement, angiolymphatic invasion, cervical involvement, expression of ER, PR, p53, PTEN, and MSI, lymph node involvement, and pathologic stage. Results: Out of the 200 cases, 186 shared the conventional immunophenotype, and 34 shared a variant immunophenotype characterized by loss of progesterone (23 cases, 67.6%), p53 mutation (16 cases, 47.1%), or PTEN wild type (five cases, 14.7%). The 34 variant cases of type 1, grade 1 endometrioid endometrial adenocarcinoma were associated with cervical involvement, extrauterine spread (eight cases, 23.5%, P = .031) and lymph node metastasis. Conclusion: There is a subset "variant" of grade 1 endometrioid endometrial adenocarcinomas that expresses a different immunophenotype compared to the conventional type. These variant grade 1 endometrioid adenocarcinomas that have loss of progesterone, p53 mutated, PTEN wild type are associated with a high-risk biology and portend a more aggressive clinical course when compared to the conventional grade 1 endometrioid adenocarcinoma. The aggressive nature of the variant grade 1 endometrioid adenocarcinoma is independent of percent of myometrial invasion. Based on these findings, it is recommended to treat these variants of grade 1 endometrioid endometrial adenocarcinomas similar to grade 3 endometrioid adenocarcinoma and due to their aggressive biology and risks of extrauterine spread, lymph node involvement, and higher stage at diagnosis to perform pelvic lymphadenectomy and stage them similar to the high grades. Management should not depend on percent of myometrial involvement due to the present finding of extrauterine disease in cases with less than 50% of myometrial involvement.
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P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees' Diagnostic Proficiency
Kieran Sultan, MD, Yuxin Liu, MD PhD, Tamara Kalir, MD, PhD; Mount Sinai Health System, New York, NY Objectives: In 2013, the nomenclature for human papillomavirus (HPV)-related lower anogenital squamous lesions was updated to a two-tiered system: high-grade squamous intraepithelial lesion (HSIL) vs low-grade squamous intraepithelial lesion (LSIL). LSIL represents transient HPV infection (CIN1); HSIL represents true cancer precursors (formerly CIN2/3). P16 immunohistochemistry (IHC) plays a critical role in the implementation of this new terminology. However, difficulties arise both in its judicious use and interpretation. Concerning p16 IHC use in grading cervical HPV-related lesions, we set out to determine pathology trainees' proficiency and interpretive skills with a goal of developing targeted, efficient training. Methods: Twelve pathology residents (PGY 2-5) participated in a survey of 20 cervical biopsies that included five unequivocal CIN1, five unequivocal CIN3, and 10 intermediate lesions (CIN2). We recorded trainees' initial H&E diagnosis (CIN1, CIN3, CIN2 requiring p16), frequency of p16 use, p16 interpretation (positive vs negative), and the final diagnosis (LSIL or HSIL) based on combined H&E and p16.
